Clinical Trials Logo

Clinical Trial Summary

This prospective, multi-center study aims to determine the pharmacokinetics and pharmacodynamics of extended-infusion cefepime in continuous renal replacement therapy (CRRT).


Clinical Trial Description

This prospective, multi-center study aims to determine the pharmacokinetics and pharmacodynamics of extended-infusion cefepime in CRRT. Patients on CRRT who are being initiated on cefepime 2000 mg IV every eight hours with a four-hour infusion will be considered for enrollment. Pre- and post-membrane serum levels will be drawn at scheduled intervals for both the first dose and again during another dose at steady state. Concomitant effluent and urine levels will also be obtained. A pharmacokinetic analysis will be performed and Monte Carlo simulations will be used to determine the probability of target attainment for various pharmacodynamic endpoints. Documented organism MICs will be used to determine the cumulative fraction of response. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02458261
Study type Observational
Source University of Cincinnati
Contact
Status Completed
Phase
Start date March 2015
Completion date February 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04659343 - TDM for Optimized Outcome in Patients With mRCC.
Recruiting NCT01565759 - In Vivo Lithium Treatment Effects on Gene Expression Levels in Lymphoblastoid Cell Lines From Human Healthy Subjects Phase 1
Completed NCT01963130 - Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study N/A
Completed NCT04690673 - Detection of Paracetamol Concentration in Blood-, Saline- and Urine Samples - a Validation Study for a Novel Technique N/A
Recruiting NCT05212389 - The Pill Project - Oral Contraceptive and Serotonergic Brain Signaling N/A